Pedro Monsalve
University of Miami
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pedro Monsalve.
Translational Vision Science & Technology | 2017
Pedro Monsalve; Giacinto Triolo; Jonathon Toft-Nielsen; Jorge Bohorquez; Amanda D. Henderson; Rafael E. Delgado; Edward Miskiel; Özcan Özdamar; William J. Feuer; Vittorio Porciatti
Purpose To compare a new method for steady-state pattern electroretinogram (PERGx) with a validated method (PERGLA) in normal controls and in patients with optic neuropathy. Methods PERGx and PERGLA were recorded in a mixed population (n = 33, 66 eyes) of younger controls (C1; n = 10, age 38 ± 8.3 years), older controls (C2; n = 11, 57.9 ± 8.09 years), patients with early manifest glaucoma (G; n = 7, 65.7 ±11.6 years), and patients with nonarteritic ischemic optic neuropathy (N; n = 5, mean age 59.4 ± 8.6 years). The PERGx stimulus was a black-white horizontal grating generated on a 14 × 14 cm LED display (1.6 cycles/deg, 15.63 reversals/s, 98% contrast, 800 cd/m2 mean luminance, 25° field). PERGx signal and noise were averaged over 1024 epochs (∼2 minutes) and Fourier analyzed to retrieve amplitude and phase. Partial averages (16 successive samples of 64 epochs each) were also analyzed to quantify progressive changes over recording time (adaptation). Results PERGLA and PERGx amplitudes and latencies were correlated (Amplitude R2 = 0.59, Latency R2 = 0.39, both P < 0.0001) and were similarly altered in disease. Compared to PERGLA, however, PERGx had shorter (16 ms) latency, higher (1.39×) amplitude, lower (0.37×) noise, and higher (4.2×) signal-to-noise ratio. PERGx displayed marked amplitude adaptation in C1 and C2 groups and no significant adaptation in G and N groups. Conclusions The PERGx high signal-to-noise ratio may allow meaningful recording in advanced stages of optic nerve disorders. In addition, it quantifies response adaptation, which may be selectively altered in glaucoma and optic neuropathy. Translational Relevance A new PERG method with increased dynamic range allows recording of retinal ganglion cell function in advanced stages of optic nerve disorders. It also quantifies the response decline during the test, an autoregulatory adaptation to metabolic challenge that decreases with age and presence of disease.
Journal of Glaucoma | 2017
Vittorio Porciatti; William J. Feuer; Pedro Monsalve; Giacinto Triolo; Luis E. Vazquez; John McSoley; Lori M. Ventura
Purpose: To obtain pilot data on posture-induced changes of intraocular pressure (IOP), systemic pressure, and pattern electroretinogram (PERG) predictive of future optic nerve tissue loss glaucoma suspects (GSs). Methods: Mean peripapillary retinal fiber layer thickness (RNFLT) was measured with optical coherence tomography 2 times/year in 28 GS aged 58±8.9 years over 5.0±0.73 years. All patients had a baseline PERG, IOP, and brachial blood pressure measurements in the seated and −10 degrees head-down-body-tilt (HDT) position. Outcome measures were seated/HDT PERG amplitude and phase, IOP, mean arterial blood pressure, and estimated ocular perfusion pressure. An additional group of 11 similarly aged controls aged 56.9±13 years was tested for comparison. Results: Although all GS had initial RNFLT in the normal range, 9/28 of them developed significant (P<0.05) loss of mean RNFLT [thinners (T)] over the follow-up period as opposed to 19/28 who did not [nonthinners (NT)]. Significant (P<0.05) differences between similarly aged controls, NT, and T were found in PERG amplitude, PERG phase, mean arterial blood pressure, IOP, and ocular perfusion pressure. A nominal logistic regression using baseline PERG and hemodynamic variables was able to distinguish T from NT with an area under receiving operator characteristic of 0.89 (SE, 0.07). Conclusions: Baseline PERG, IOP, and systemic blood pressure, together with their changes upon HDT, may have predictive value for future loss of optic nerve tissue in GS. This study supports the rationale for a full-scale clinical trial to identify patients at high risk of development of glaucoma.
Journal of Glaucoma | 2018
Gustavo Rosa Gameiro; Pedro Monsalve; Iuri Golubev; Lori M. Ventura; Vittorio Porciatti
Journal of Pediatric Ophthalmology & Strabismus | 2016
Kara M. Cavuoto; Pedro Monsalve; Ta C. Chang
Documenta Ophthalmologica | 2018
Pedro Monsalve; S. Ren; G. Triolo; Luis E. Vazquez; Amanda D. Henderson; M. Kostic; P. Gordon; William J. Feuer; Vittorio Porciatti
American Journal of Ophthalmology | 2018
Swarup S. Swaminathan; Pedro Monsalve; Xiao Yi Zhou; Mabel Enriquez-Algeciras; Sanjoy K. Bhattacharya; Sander R. Dubovy; Anna K. Junk
Investigative Ophthalmology & Visual Science | 2017
Pedro Monsalve; Gustavo Rosa Gameiro; Giacinto Triolo; John McSoley; Kara M. Cavuoto; William J. Feuer; Luis E. Vazquez; Vittorio Porciatti
Investigative Ophthalmology & Visual Science | 2017
Anny Rodriguez; William J. Feuer; Gustavo Rosa Gameiro; Susy Pachon; Pedro Monsalve; Jean-Claude Mwanza; Donald L. Budenz; Luis E. Vazquez
Investigative Ophthalmology & Visual Science | 2016
Giacinto Triolo; William J. Feuer; Pedro Monsalve; Luis E. Vazquez; John McSoley; Lori M. Ventura; Vittorio Porciatti
Journal of Aapos | 2015
Pedro Monsalve; Ta C. Chang; Kara M. Cavuoto